0001127602-23-002753.txt : 20230131
0001127602-23-002753.hdr.sgml : 20230131
20230131165146
ACCESSION NUMBER: 0001127602-23-002753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230130
FILED AS OF DATE: 20230131
DATE AS OF CHANGE: 20230131
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eisele Jeffrey
CENTRAL INDEX KEY: 0001827326
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 23573173
MAIL ADDRESS:
STREET 1: APELLIS PHARMACEUTICALS, INC.
STREET 2: 100 5TH AVENUE, 3RD FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 617-977-5700
MAIL ADDRESS:
STREET 1: 100 FIFTH AVENUE
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2023-01-30
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001827326
Eisele Jeffrey
C/O APELLIS PHARMACEUTICALS, INC.
100 FIFTH AVENUE, 3RD FLOOR
WALTHAM
MA
02451
1
Chief Development Officer
Common Stock
2023-01-30
4
S
0
883
52.76
D
46468
D
Sale originated from established 10b5-1 trading plan.
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
2023-01-31